Navigation Links
Omnilux New-U(TM) Hand-Held Device Receives FDA Approval
Date:3/12/2008

Photo Therapeutics, Inc., leaders in light therapy, proudly receives its

6th FDA approval

CARLSBAD, Calif., March 12 /PRNewswire/ -- Photo Therapeutics, Inc. is pleased to announce it has received FDA approval on its new over-the-counter light therapy device, Omnilux New-U, for the treatment of periorbital wrinkles.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080312/LAW011)

Omnilux New-U has been clinically proven to reduce periorbital wrinkles and to treat the visible signs of aging, using a combination of alternate treatments of infrared and red light twice a week for four weeks.

The clinical study conducted by Neil Sadick, Weill Medical College of Cornell University Department of Dermatology, New York, demonstrated a significant reduction in periorbital wrinkles and improvements in skin tone, clarity, smoothness and elasticity.

"This is a pivotal point in the history of the company and its development of light-based technologies. We are extremely proud of our medical heritage. We believe in producing light therapy devices that deliver optimized treatment parameters that have been rigorously tested and clinically proven, and our latest technological achievement is no different," said Sue D'Arcy, CEO of Photo Therapeutics, Inc. "We are excited that we can now offer Omnilux technology directly to the consumer marketplace without a prescription."

Photo Therapeutics, Inc. was established in 1998 with the right to the patented photodynamic therapy technology, the Paterson Lamp. Originating from the University of Manchester Institute of Science and Technology (UMIST) and years of cumulative research, the technology was launched commercially in 1998 as Omnilux.

The now widely recognized Omnilux Light Therapy system offers single platform technology with the versatility of multiple treatment heads for the treatment of acne, wrinkle reduction, skin rejuvenation, wound healing, psoriasis and photodynamic therapy.

To learn more, visit the Omnilux website at http://www.phototherapeutics.com or email info@phototherapeutics.com.


'/>"/>
SOURCE Photo Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hand-held computers prod older adults to exercise more, Stanford study shows
2. MSU engineering team designs innovative medical device
3. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
4. Implantable device designed to detect, stop seizures under study at MCG
5. Visiprise Launches Podcast Series with AMR to Support Medical Device Manufacturers
6. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
7. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
8. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
9. Mobility-enhancing device developed at University of Alberta will receive prestigious da Vinci Award
10. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
11. FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
Breaking Medicine Technology: